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Dosage-Dependent Gene Regulation in Multicellular
Eukaryotes: Implications for Dosage Compensation,
Aneuploid Syndromes, and Quantitative Traits
James A. Birchler,1 Utpal Bhadra, Manika Pal Bhadra,
and Donald L. Auger
Division of Biological Sciences, University of Missouri, Columbia, Missouri 65211
Evidence from a variety of data suggests that regulatory mechanisms in multicellular eukaryotes have evolved in such a
manner that the stoichiometric relationship of the components of regulatory complexes affects target gene expression. This
type of mechanism sets the level of gene expression and, as a consequence, the phenotypic characteristics. Because many
types of regulatory processes exhibit dosage-dependent behavior, they would impact quantitative traits and contribute to
their multigenic control in a semidominant fashion. Many dosage-dependent effects would also account for the extensive
modulation of gene expression throughout the genome that occurs when chromosomes are added to or subtracted from the
karyotype (aneuploidy). Moreover, because the majority of dosage-dependent regulators act negatively, this property can
account for the up-regulation of genes in monosomics and hemizygous sex chromosomes to achieve dosage
compensation. © 2001 Academic Press
Key Words: gene regulation; dosage effects; aneuploidy; dosage compensation; quantitative traits; sex chromosomes;
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SINTRODUCTION
Gene expression in bacteria and unicellular eukaryotes is
highly responsive to environmental conditions, often turn-
ing on or off related genes under different circumstances. In
multicellular eukaryotes, this is rarely so. Nevertheless, in
this review, we argue that gene-expression mechanisms
have evolved in multicellular eukaryotes to be externally
responsive in a different manner. Selection on the pheno-
type forces the mechanisms of transcriptional regulation to
be “rate limiting” on phenotypic characteristics in the
diploid state via their effect on target genes. This sets the
extent of growth, the size of organs, the amount of metabo-
lites, etc., making their control dosage-dependent.
The evidence that a single process or target gene is
affected by multiple dosage-dependent factors began to
emerge over twenty years ago from different types of
studies. Henikoff (1979) and Reuter and Wolf (1981) found a
1 To whom correspondence should be addressed. Fax: (573) 882-
0123. E-mail: BirchlerJ@Missouri.edu.
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All rights of reproduction in any form reserved.arge number of dominant mutations in Drosophila that
odify the phenomenon of position effect variegation—the
osaic expression of genes that often occurs with novel
uxtapositions of euchromatin and heterochromatin. Heni-
off predicted “it is reasonable to expect that the Drosoph-
la genome contains hundreds of loci that can modify
ariegation.” And indeed there are (Reuter and Wolf 1981;
inclair et al., 1983; Weiler and Wakimoto, 1995). The
second line of evidence came from chromosomal dosage
experiments in maize and Drosophila. Changing the dosage
of chromosomal segments alters the expression levels of
various genes encoded elsewhere in the genome (Birchler,
1979; Birchler and Newton, 1981; Sabl and Birchler, 1993).
In some cases, the trans-acting effects were a positive, i.e.,
the target gene expression increased as did the copy number
of the chromosomal segment. With a negative effect, gene
expression decreases as the dosage of the effective chromo-
somal segment increases. A negative or “inverse effect” is
the more common type in both maize and Drosophila.
Two-thirds to three-quarters of the modifiers act “in-
versely.” The reason for this is unknown. Eventually, single
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276 Birchler et al.genes were identified that fulfilled the predictions as being
responsible for the dosage series effects (e. g., Rabinow et
TABLE 1
Dosage-Dependent Modifiers of the white Eye Color Gene of Dros
Modifier E
abnormal, small, homeotic discs 2 (ash2) N
apterous (ap) N
Beadex (Bd) N
brahma (brm) P
cap-n-collar (cnc) N
devenir (dev) N
Distalless (Dll) N
Enhancer of Polycomb (E(Pc)) N
Enhancer of white-spotted[81d5] P
Enhancer of zeste (E(z)) N
extra sex combs (esc) N
hedgehog (hh) P
Inverse regulator-a (Inr-a) N
kismet (kis) P
kohtalo (kto) N
l(2) 05208/Kruppel-homolog1 (Kr-h1) P
l(2) 03405/Uba1 P
l(3) 00305 N
l(3) 01969 N
l(3) 02104 N
l(3) 03670 N
l(3) 04063 N
l(3)04026 N
l(3)08232 N
l(3)87Ca/Vha55 P
Lightener of white (Low) P
mei-P19 N
Modifier of white (Mow) N
modulo (mod) N
osa (osa) P
oxen (ox) N
Polycomblike (Pcl) N
Posterior sex combs (Psc) N
Regena (Rga) N
Ribonuclear protein at 97D N
Ribosomal protein PO/AP lyase (PO) N
scalloped (sd) N
Sex combs on midleg (Scm) N
skuld (skd) N
sugarless (sgl) N
Suppressor of Polycomb (Su(Pc)) N
Trithoraxlike (Trl) P
Ultrafemale overexpression (Ufo)/lola N
urdur (urd) N
verthandi (vtd) N
Weakener of white (Wow) P
wingless (wg) N
Note. Modifiers of white were determined by the increase or decr
ll the listed modifiers have an effect on white as heterozy
osage-dependent nature of their action. Further descriptions
ybase.bio.indiana.edu:82/).l., 1991). Functional copies of regulatory genes that are t
Copyright © 2001 by Academic Press. All righteterozygous with null mutations would be equivalent to a
onosomic chromosomal segment and usually increase
la
on white Type of regulator
ve Transcription factor
ve LIM family transcription factor
ve Transcription factor
e Chromatin remodeling
ve bZIP transcription factor
ve Trithorax-Group
ve Transcription factor
ve Polycomb Group
e Unknown
ve Polycomb Group
ve Polycomb Group
e Cell–cell signaling
ve Unknown
e Trithorax-Group
ve Trithorax-Group
e Transcription factor
e Ubiquitin activating
ve Unknown
ve Unknown
ve Unknown
ve Unknown
ve Unknown
ve Unknown
ve Unknown
e Polycomb Group
e Unknown
ve Unknown
ve Unknown
ve DNA binding
e DNA binding
ve Diacyl glycerol kinase
ve Polycomb Group
ve Polycomb Group
ve Transcription factor
ve Nuclear RNA binding
ve AP3 DNA endonuclease
ve Transcription factor
ve Transcription factor
ve Trithorax-Group
ve UDP-G6DH (signaling)
ve Polycomb Group
e Transcription factor
ve Transcription factor
ve Trithorax-Group
ve Trithorax-Group
e/negative Unknown
ve Cell–cell signaling
of pigment levels in flies carrying leaky point mutations of white.
with their respective normal allele, thus demonstrating the
references for each gene can be found in Flybase (http://ophi
ffect
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andarget gene expression. However, there is evidence that
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277Gene Regulation in Multicellular Eukaryotesboth positive and negative effects can be produced by the
same gene under different circumstances (Birchler et al.,
1994; Bhadra et al., 1997).
It is now clear that the modifiers of variegation and of
ene expression overlap (Dorn et al., 1993; Birchler et al.,
994; Csink et al., 1994; Bhadra and Birchler, 1996; Bhadra
t al., 1997; Frolov et al., 1998; Frolov and Birchler 1998;
enikoff, 1996). These genes encode a heterogeneous col-
ection of regulatory molecules ranging from transcription
actors to chromatin proteins to members of signal trans-
uction pathways that ultimately modulate transcription.
he heterogeneous nature suggests that many aspects of
ene regulation are subject to selection for rate-limiting
ction in the diploid state.
To define the number and nature of trans-acting dosage-
ependent factors that influence a single target, leaky
lleles of the X chromosome linked white eye color gene in
rosophila were used as a monitor (Table 1). These alleles
rovided an inexpensive and rapid screen for such modifi-
rs. They allowed the detection of quite subtle phenotypic
ffects that even the most sensitive molecular technique
ight miss. It is important to document even the more
ubtle modifiers in such a model system in order to deter-
ine the types of genes that affect quantitative variation. In
eneral, all such modifiers have the potential to influence
rtificial and natural selection for any characteristic under
onsideration. At least 47 dosage-dependent modifiers of
hite have been identified to date and it is likely that
thers exist. In fact, modifiers on the X chromosome are
robably significantly underrepresented because white is
lso on the X, making screens there more difficult to
onduct. Nevertheless, Muller (1950) provided evidence for
osage-dependent modifiers of white along the X with a
FIG. 1. Heuristic model of a dosage-regulatory hierarchy. Consid
dosage-dependent regulatory genes that modify its expression direc
so on, it would take only three hierarchical levels to account for the
are dosage-dependent, any modulation of their concentration by e—
be transmitted through the hierarchy to the monitored gene or ph
epistasis, and pleiotropy would complicate the interactions.predominance of negatively acting factors.
Copyright © 2001 by Academic Press. All rightThe majority of the white modifiers that have been
efined at the molecular level are involved in various
egulatory mechanisms. It has not been documented which
nes act directly versus indirectly on the white gene, but it
is highly probable that both are represented. It is also
possible that steps subsequent to the transcription of white
are modified to some degree, but there is little evidence for
such effects. Because they all exhibit a dosage effect, it is
likely that a hierarchy is operating in which an effect is
transmitted through a cascade of concentration-dependent
steps. Changing the concentration of a regulator at the top
of the hierarchy changes the concentration of its targets,
which in turn alters the amount of subsequent targets and
so on until the ultimate housekeeping gene is modulated
(Fig. 1). A hierarchy of dosage-dependent steps helps explain
why there are so many factors that affect a single gene or
process. With only a few hierarchical levels, numerous
modifiers become effective on any monitored gene.
With so many modifiers of a single target gene, it is of
interest to know the result of varying several of them
simultaneously. The evidence suggests that, although in-
teractions and epistasis are present, the net effect of mul-
tiple modifiers in most cases does not routinely surpass the
effect of a single regulatory gene. In other words, a one-,
two-, and three-dose series of a chromosome arm does not
exceed the maximal effects of a dosage series of an indi-
vidual factor. For example, in a direct correlation, the
expression of a target gene expression might be reduced
with one dose of a regulatory factor to a minimum of 50%
of the normal two-dose diploid level and increased in three
doses to a maximum of 150%. More often, an inverse
correlation occurs in which having only one dose of a
regulatory factor results in a target gene expression elevated
the expression of hypothetical gene X, if there are as few as four
nd for each of those there are four dosage-dependent modifiers and
es of dosage-dependent modifiers of gene X. Because regulators a–d
c. will be conveyed to gene X. In this manner, dosage effects would
ype. It is recognized that reticulation among hierarchy branches,ering
tly, a
scor
t, et
enotto a maximum of 200% of the normal level and the
s of reproduction in any form reserved.
f
d
d
B
B
f
o
e
a
i
q
w
w
p
278 Birchler et al.three-dose situation causes reductions in gene expression to
a minimum of 67%. Despite the fact that changing the
dosage of a single regulatory gene can achieve the direct or
inverse correlative limits (Rabinow et al., 1991), aneuploids
or rather substantial fractions of the genome, that un-
oubtedly carry several modifiers of one gene, still produce
osage effects within the same range (Birchler, 1979;
irchler and Newton, 1981; Devlin et al., 1988; Guo and
irchler, 1994; Auger et al., 2001). It appears that the dosage
FIG. 2. Dosage effects and compensation. Relative gene expres-
sion per cell using 100% as the diploid level is used to illustrate the
types of gene-expression effects observed in individuals with one,
two, or three copies of a chromosome. When chromosomal seg-
ments carrying a specific gene are varied in a dosage series, the
structural gene may exhibit a dosage effect as a reflection of the
number of copies present (Top). The most common trans-acting
dosage effect is an inverse correlation between the dosage of the
varied chromosome arm and the expression of the gene per cell
(Middle). When a structural gene is varied together with a segment
of the genome that produces an inverse dosage effect upon its
expression, the two effects of the structural gene dosage and the
inverse effect cancel each other to result in dosage compensation
(Bottom). Modified from Bhadra et al. (1999) by permission.effects result from an altered stoichiometry of regulatory
Copyright © 2001 by Academic Press. All rightactors encoded on the varied chromosome interacting with
thers whose concentrations are unchanged, as occurs, for
xample, with the myc/max/mad interactions (Grandori et
l., 2000).
Further insight into this issue comes from combining
ndividual modifiers of white. Single, double, triple, and
uadruple combinations of mutant modifiers, heterozygous
ith normal alleles, all produce an approximate doubling of
hite gene expression relative to normal rather than a
rogressive increase (Bhadra et al., 1998). There is some
degree of cumulative action among different genes, but
generally the effects fall within the inverse correlation
limits (Bhadra et al., 1998). Thus, the most common aneu-
ploid effect, regardless of the length of chromosome varied,
is an inverse correlation between the dosage of the varied
segment and the expression of the target gene.
Because the inverse effect is global in modifying target
genes in the varied segment as well as in the remainder of
the genome, the majority of genes experience dosage com-
pensation in aneuploids involving substantial chromo-
somal length (Birchler, 1979, 1981; Birchler et al., 1990;
Birchler and Newton, 1981; Devlin et al., 1982, 1988; Guo
and Birchler, 1994). Therefore, rather than reflecting gene
dosage, the expression levels of housekeeping genes present
on varied chromosomal segments in a one-, two-, and
three-dose series are often relatively constant. Obviously, at
least some of the inversely acting regulatory genes in the
varied segment must be dosage-dependent and those genes
elsewhere in the genome with which they stoichiometri-
cally interact must not be changed in expression in order to
produce the trans effects and compensation of the target
genes. Segments composed of only 5–10% of the genome
exhibit compensation for many of the included genes in
both maize (Birchler, 1979; Guo and Birchler, 1994) and
Drosophila (Devlin et al., 1982, 1988; Birchler et al., 1990).
Subdivision of these aneuploid regions showed that the
basis of the dosage compensation was a cancellation of a
gene-dosage effect by an inverse dosage effect produced by
the same chromosome arm (Birchler, 1981, 1990). That is,
when only a single copy of a chromosome arm is present, a
housekeeping gene on that arm might be expected to be
expressed at only 50% of the normal diploid amount.
However, inversely acting regulators of that gene are also
varied in the same region, causing the single copy of the
housekeeping gene to be increased two-fold in expression.
This situation results in a net expression level more or less
equivalent to the diploid (see Fig. 2). When the same
segment is present in three copies instead of the normal
two, there are now three copies of the housekeeping gene.
The concomitant inverse effect, however, reduces the ex-
pression of each copy to about two-thirds of the normal
level. The effect of an increased number of structural genes
is cancelled by the reduced expression of each copy. To
summarize, as an aneuploid segment involves an increasing
portion of the genome, the probability rises that genes on
the varied segment will be dosage-compensated. Concomi-
s of reproduction in any form reserved.
a
m
b
1
t
a
s
o
i
w
e
b
t
w
c
c
f
m
e
s
e
t
l
h
i
a
h
(
m
a
s
a
r
e
l
1
h
i
s
e
p
L
m
a
c
T
t
w
U
i
(
t
m
279Gene Regulation in Multicellular Eukaryotestantly, the expression of genes elsewhere in the genome has
a greater probability of being negatively affected.
DOSAGE COMPENSATION OF SEX
CHROMOSOMES
Given that dosage compensation occurs for the majority
of genes when virtually any chromosomal segment is varied
in dosage, the issue arises of dosage compensation of
X-linked genes (Muller, 1932). Throughout the plant and
animal kingdoms, sex-determination mechanisms are often
associated with changes in chromosomal dosage in which
one member of a homologous pair of chromosomes has
become degenerate or missing (Charlesworth, 1996). Modu-
lation of gene expression must occur for the remaining
active member of the pair because the situation is analo-
gous to a monosomic condition, which, for any other
chromosome of the complement, would be highly detri-
mental or lethal. The nature of this modulation has been
examined in extensive detail in very few species with
heteromorphic (or XO) sex chromosomes (only Drosophila,
Caenorhabditis elegans, mammals). Two interpretations
have been made. One is that there is an increase in
expression of the single sex chromosome (Drosophila). The
other is that there is a reduction to half the normal
expression in the sex that possesses the two functional
chromosomes (mammals; C. elegans) (reviewed by Cline
and Meyer, 1996; Baker et al., 1994). Because this latter
scenario suggests that there is an evolution toward a con-
dition similar to monosomy, which is otherwise lethal
(Rosenbluth and Baillie, 1981; Rose et al., 1984; Sigurdson
et al., 1984; see discussion by Graves et al., 1998), the
interpretation of the evolution of these systems should be
reexamined. A scenario that should be considered is that a
single X in males (or its equivalent in females with X
inactivation) has doubled expression. If the mechanism of
male increase also operates in females or there is a selection
pressure to equalize autosomal expression following such
changes, then the down-regulation of the Xs in females
would follow, as suggested by Charlesworth (1978). The end
product would be an equal per cell expression of male and
female sex-linked genes, but a doubled per gene expression
relative to the progenitor state before the formation of sex
chromosomes.
Indeed, in mammals, one of the two X chromosomes in
females is inactivated (reviewed by Lyon, 1999). However,
recent evidence has suggested that a gene on the single X in
male mice is up-regulated two-fold relative to its progenitor
(Adler et al., 1997; Graves et al., 1998). While the change in
expression is of the proper magnitude, it is unknown
whether this is a response to an inverse dosage effect that
typically occurs in experimental “monosomics” or whether
it is brought about by some other mechanism. Further
experiments will be necessary to understand more fully the
evolution of gene expression from the sex chromosomes in
mammals. (
Copyright © 2001 by Academic Press. All rightIn Drosophila, it is clear that dosage compensation is
chieved by an up-regulation of the single X chromosome in
ales (Arkhipova et al., 1997). The basic mechanism has
een suggested to rely on the inverse dosage effect (Birchler,
977, 1979, 1996). The two-fold increase in expression of
arget X-linked genes in males is thought to be brought
bout by the net effect of altered stoichiometry of gene-
pecific transcription factor complex components encoded
n the X versus those encoded on the autosomes. The
nvolvement of the inverse effect in dosage compensation
as demonstrated by the behavior of the X-derived white
ye color gene transgenically inserted into an autosome in a
ackground where the endogenous white was deleted from
he X. In its new autosomal location, the expression of
hite was inversely modulated by the dosage of the X
hromosome (Birchler, 1992). One copy of the X in males
onditions the highest expression; two copies of the X in
emales are intermediate; and three copies in so-called
etafemales are the lowest. When the white gene was
xamined on the X chromosome, an X dosage series con-
isting of males, females, and metafemales all had similar
xpression, indicating that dosage compensation extends to
he three-copy X genotype (Birchler, 1992; see also, Margo-
is, 1934; Stern, 1960). Moreover, mutant alleles of white
ave been identified that fail to show dosage compensation
n males, having lower expression than females. These
lleles also fail to show compensation in metafemales,
aving greater expression than the normal females
Birchler, 1992). This finding indicates that the same
echanism of dosage compensation operates in both males
nd metafemales.
If the inverse dosage effect is responsible for X chromo-
omal dosage compensation, one might predict that a dos-
ge series of the sex chromosome would produce an inverse
esponse on the autosomes. Indeed, metafemales have the
xpression of many autosomal genes reduced to an apparent
ower limit of two-thirds of the female level (Birchler et al.,
989). However, in males, where the expression of genes
as been subjected to evolutionary selection, the situation
s not so simple. In this case, the expression of the auto-
omes is quite similar to females, although when differ-
nces do exist, the most common autosomal sexual dimor-
hism is a higher gene expression in males (Smith and
ucchesi, 1969; Birchler, 1984).
Clearly, the expression of the single X chromosome in
ales has been modified during evolution, because it is
ssociated with a set of distinctive chromosomal proteins
alled the male-specific lethal (MSL) complex (see Fig. 3).
his fact became known by analyzing a set of mutations
hat, when homozygous, were lethal to males, but for
hich females could survive (Belote and Lucchesi, 1980).
sing antibodies against these proteins, it was found that,
n males, they are specifically located on the X chromosome
Kuroda et al., 1991). The complex is composed of at least
he products of the male-specific lethal 1, 2, and 3 loci, the
aleless locus, the males absent on the first (mof) geneHilfiker et al., 1997), the JIL1 kinase (Jin et al., 1999, 2000),
s of reproduction in any form reserved.
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280 Birchler et al.and at least two noncoding RNAs (roX1, roX2) (Meller et al.,
1997). The mof gene product is a histone acetyltransferase
specific for H4 Lys16 residues (Hilfiker et al., 1997; Aktar
and Becker, 2000). The JIL1 kinase phosphorylates histone
H3 (Jin et al., 1999, 2000). All of these genes are expressed
in males and females, except msl2, whose encoded protein
is present normally only in males. Its product is instrumen-
tal in targeting the complex to the X (Kelley et al., 1995).
This localization appears to initiate at several nucleation
sites from which spreading occurs over a considerable
distance (Bhadra et al., 1999; Kelley et al., 1999) to cover the
chromosome. The presence of the complex on the X chro-
mosome in males leads to an increase in the level of histone
4 lysine 16 acetylation (Turner et al., 1992; Bone et al.,
1994). (It is assumed that histone phosphorylation catalyzed
by JIL1 kinase is similarly affected, although this issue is
still unresolved.) These chromosomal-labeling studies led
to the hypothesis that the presence of the MSL complex on
the X in males brought about the increased acetylation of
H4 and that this modification caused a two-fold increase in
X chromosomal gene expression to achieve dosage compen-
sation. Again, however, the situation is not so simple.
When absolute levels of gene expression from the X and
the autosomes were examined in larvae mutant at the msl
loci, there was little impact on the X-linked genes sampled,
but the most common effect on autosomal genes was an
increase in expression in males (Hiebert and Birchler, 1994).
Under these circumstances, the MSL complex is not bound
to the X. Therefore, it is unlikely to be the primary
determinant of dosage compensation, because, for the most
part, dosage compensation of X-linked genes is still opera-
tive in its absence. Interestingly, the genome wide expres-
sion pattern is now as predicted by the prevalence of the
inverse dosage effectors, namely, compensation of most
target genes on the X and a near doubling of overall
expression of the autosomes (Hiebert and Birchler, 1994;
Birchler, 1996).
Further investigation of the binding properties of the MSL
complex showed that a partial complex is uniformly dis-
tributed on all chromosomes in females (Bhadra et al.,
1999). The H4 acetylation is also uniform. A similar situa-
tion occurs in the dipteran Sciara, where a partial complex
is present on all chromosomes in both males and females
and shows no specific association with the sex chromo-
somes (Ruiz et al., 2000). However, in Drosophila males,
the acetylation is higher on the X and lower on the
autosomes compared to females, because MOF is seques-
tered to the X in males (Fig. 4). In msl mutant males and
females, there is no binding of the complex to any chromo-
some, but MOF binds uniformly at a low level on its own in
the absence of the MSL complex (Fig. 4) and is catalytically
active in modifying H4 (Bhadra et al., 1999, 2000). There-
fore, the acetylation level on the X in mutant msl males
goes down, but goes up on the autosomes compared to
normal males. When gene expression is monitored in situ-
ations in which the acetylation level increases or decreases
on the autosomes, gene expression parallels the H4 acety- n
Copyright © 2001 by Academic Press. All rightlation level (Bhadra et al., 1999, 2000). This finding is in
accordance with the general rule that histone acetylation
creates a more open chromatin configuration leading to
increased gene expression (Brownell and Allis, 1996). The
sequestration of histone modifiers to the X in males may
have evolved to counteract the increased expression of the
autosomes that might otherwise have occurred due to the
inverse dosage effect produced by the single copy of the X
chromosome.
In contrast, genes on the X do not respond to the high
levels of H4 acetylation that are present in normal males
(Bhadra et al., 1999, 2000). Nor do genes on the X increase
in expression when the acetylation level is raised by direct-
ing the MSL complex to the Xs in females (Bhadra et al.,
1999, 2000). These observations led to the concept that
some component of the MSL complex inhibits genes from
responding to the high level of acetylation. The results also
indicate that the MSL complex itself is not the determinant
of hyperactivation of the X. Indeed, when MOF alone is
artificially targeted to a gene, the acetylation increases as
well as the level of expression, but the latter is severalfold
greater than needed to account for dosage compensation
(Akhtar and Becker, 2000). The MSL complex on the X in
males may inhibit this response so as to allow target genes
to respond to the two-fold inverse dosage effect, which
provides the proper level of modulation to achieve dosage
compensation.
ANEUPLOID SYNDROMES
Having discussed the genome modifications of sex chro-
mosomes needed to respond to the multitude of dosage-
dependent regulatory genes, we can now turn our attention
to how regulatory genes might cause aneuploid syndromes
in situations where no selection pressure has occurred. In
both plants and animals, increases or decreases in chromo-
somal dosage have a significant impact on the phenotype
(Blakeslee et al., 1920; Patterson et al., 1937; Lindsley et al.,
972; Epstein, 1986; Bond and Chandley, 1983). As the
ength of the varied region increases, the probability that
ethality will result becomes greater. As a general rule,
onosomy is more severe than trisomy, but both are less
igorous than the normal euploid.
It is likely that the various vigor relationships among
neuploids have their basis in the level of target gene
xpression in the respective genotypes (Birchler and New-
on, 1981). With both positive and negative dosage effects
perating in aneuploids, reductions of target gene expres-
ion will occur in both monosomics and trisomics as
emonstrated in maize (Birchler and Newton, 1981; Guo
nd Birchler, 1994; Auger et al., 2001). The positive effects
esult from noncompensated structural genes present on
he varied chromosome and from positively acting trans
ffects on target genes elsewhere in the genome. In mono-
omics, the lowest reductions are typically 50% of the
ormal diploid amount. In trisomics, there are also reduc-
s of reproduction in any form reserved.
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281Gene Regulation in Multicellular Eukaryotestions in gene expression. In this case, they result from an
inverse dosage effect on genes encoded elsewhere in the
genome. The lowest reductions are at the 67% value
relative to normal. Many effects only occur in either mono-
somics or trisomics rather than the whole dosage series, but
the range still falls within these limits (Guo and Birchler,
1994; Auger et al., 2001). If the expression of different sets
of target genes are reduced in the monosomic and trisomic,
then different gene products become rate limiting on vigor
and the respective aneuploid syndromes would result
(Birchler and Newton, 1981; Guo and Birchler, 1994). Aneu-
ploidies of the various chromosomes of the karyotype will
modify different groups of target genes and thus produce
unique phenotypes. The classical thinking on this issue is
FIG. 3. Heteromorphic sex chromosomes and the modification of
s depicted that would result without evolutionary modifications
equestered to the X in males at the expense of its presence on the
he expression of msl2, a critical component of the male-specifi
istribution of histone acetyltransferase and JIL1 histone kinase a
rotein sequesters the complex together with the MOF histone a
onsequence of this sequestration in males is that the autosomes
hile these chromatin modifications are increased on the X. Ther
he reduced acetylation and phosphorylation. On the X, the chro
ajority, the MSL complex prevents a response to the high levels o
ffect to provide the proper level of X chromosomal dosage compethat an imbalance of gene products from the varied region
Copyright © 2001 by Academic Press. All rightelative to the remainder of the genome is detrimental to
he organism (Blakeslee et al., 1920). The analysis of gene
xpression in aneuploids, however, demonstrates that dos-
ge compensation occurs for the majority of varied genes
ut the remainder of the genome is modulated to varying
egrees. The “imbalance” appears to be a reflection of the
toichiometric alterations of components of regulatory
omplexes rather than of the target gene expression, al-
hough it is difficult to separate the two. The situation is
omplex, but the facts that greater reductions of target gene
xpression occur in monosomics than in trisomics and that
hese changes more or less parallel the phenotypic conse-
uences suggest that the aneuploid syndromes are caused
y the dosage effects (Fig. 5).
ic expression in Drosophila. At the top of the figure, the situation
he sex chromosomes. Below is shown how the MSL complex is
somes. The Sxl gene is expressed only in females, where it blocks
hal complex for X sequestration. In females, there is a uniform
ll as a partial MSL complex. In males, the presence of the MSL2
ase and JIL1 kinase for association with the X chromosome. The
educed for their level of histone acetylation and phosphorylation,
, the inverse dosage effect of the X on the autosomes is muted by
n modification alters the expression of a few genes, but for the
ylation and phosphorylation, allowing the two-fold inverse dosage
on.genom
of t
auto
c let
s we
cetyl
are r
efore
mati
f acetIn contrast to the extensive modulations of gene expres-
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282 Birchler et al.FIG. 4. Sequestration of MOF histone acetyltransferase to the X chromosome and the impact on gene expression. (A) Distribution of MOF
in different genotypes. (a) Mixture of salivary gland polytene nuclei from normal males and females stained for DNA with propidium iodide
(PI) (red). (b) The same nuclei probed with antibodies to MOF (green). A nucleus of each sex is enlarged below with the anti-MOF pattern
and the image merged with PI. Note the enrichment of MOF on the X chromosome in males, but the uniform genomic distribution in
females. (c) Mixture of salivary gland polytene nuclei from normal and mle/mle males. (d) The same nuclei probed with antibodies to MOF.
Below are enlarged individual nuclei of each genotype. Note the sequestration of MOF to the X in normal males, but the return of MOF
to all chromosomes in the mle mutant males, where no MSL complex is formed. Thus, normal males have greater amounts of MOF on the
X and lesser amounts on the autosomes compared to females. In the mle mutant males, there is less MOF on the X and greater amounts
on the autosomes compared to normal males. (B) Gene expression consequences of MOF sequestration. A full-length white transgene was
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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283Gene Regulation in Multicellular Eukaryotession that occur with aneuploids, changes in the dosage of
the whole genome in a ploidy series have much less impact
(Lucchesi and Rawls, 1973; Birchler and Newton, 1981; Guo
et al., 1996; Birchler et al., 1990; Rabinow et al., 1991). In
this case, there is a tendency for genes to exhibit a per cell
expression that is directly correlated with ploidy. In most
but not all cases, increased ploidy causes a correlated
increase in cell size; thus, in general, the gene products are
at a similar concentration per cell among different ploidies.
Nevertheless, some genes have a greater or lesser expres-
sion with increasing ploidy (Guo et al., 1996). These obser-
vations are consistent with the suggestion that the aneu-
ploid effects result from the altered stoichiometry of
transcriptional regulators.
RELATIONSHIP TO QUANTITATIVE
TRAITS
The multiplicity of dosage effects on a single target gene
(or a single phenotype) also suggests a basis for the poly-
genic nature of quantitative traits (Guo and Birchler, 1994;
Bhadra et al., 1998). Most mutations exhibit a strong
dominant/recessive relationship with normal alleles
(Stadler, 1928; Orr, 1991) and are the basis of discontinuous
(qualitative) traits. However, a major tenet of quantitative
genetics is that many traits exhibit an intermediate pheno-
type, at least to some degree, in hybrids between parents
representing the extremes of the population. The genetic
control of such phenotypes is continuously distributed in
subsequent generations (for recent reviews, see Tanksley,
1993; Mackay, 1995). This behavior suggests a control by
which there are many genes contributing to the trait and
that, for many of them, the alleles from the different
parents show a dosage effect to some degree in the hybrid.
Thus, it is likely that much of quantitative variation has a
basis in the behavior of dosage-dependent regulatory genes
(Guo and Birchler, 1994; Byrne et al., 1996; Doebley et al.,
1997; Lukens and Doebley, 1999; Frary et al., 2000). Stated
another way, with the knowledge that many dosage-
dependent regulatory genes will affect any single gene or
trait, one would predict the type of genetic control of the
phenotype that quantitative characters generally exhibit.
The dosage hierarchy described above unifies the polygenic
nature of additive quantitative traits with the observation
that any one characteristic is affected by multiple aneu-
ploidies.
assayed on the X or on the third chromosome in normal and m
background with a deletion of the normal white gene. Northern an
compensation occurs even in the mle/mle genotype. For the transge
occurs between normal males and females with males being high
ignificantly (denoted by *) increased relative to the normal male
easurements of the white/tubulin ratio in the four genotypes f
ene-expression studies suggest that the mle mutants show no im
ence H4 acetylation cause an increased expression. Modified from Bh
Copyright © 2001 by Academic Press. All rightTwo examples illustrate the nature, behavior, and hierar-
hy of quantitative trait loci. The teosinte-branched (tb1)
ocus of maize is a negatively acting transcription factor
hat is a repressor of organ growth (Doebley et al., 1997).
uring the domestication of maize, the expression of tb1
as been up-regulated approximately two-fold to suppress
he highly branched morphology typical of the maize pro-
enitor, teosinte. The up-regulation of tb1 requires alleles
t other loci, illustrating hierarchial interactions (Lukens
nd Doebley, 1999). Secondly, in tomato, fruit size is
ontrolled by many loci. A major quantitative trait locus for
his character, fw2.2, has been cloned and found to have
omology to the human oncogene ras, which exerts a
egulatory control of cell division (Frary et al., 2000). The
small-fruit allele of this gene is semidominant to the
large-fruit allele. Transformation of the gene back into
tomato showed that a transgenic copy of fw2.2 reduced fruit
size, indicating that this gene acts negatively on the quan-
titative trait. The common alleles of this locus appear to
differ by changes that affect the expression rather than the
structure of the protein itself, suggesting the potential for
hierarchial modulations of fw2.2 by other regulatory genes
that would contribute to the overall quantitative trait.
RELATIONSHIP TO DEVELOPMENTAL
PROCESSES
This type of concentration-dependent behavior is also
exhibited by many regulators that control developmental
decisions (Driever and Nusslein-Volhard, 1988; Struhl et
al., 1989; Warrior and Levine, 1990; Sauer and Jackle, 1991;
Jiang and Levine, 1993; Weintraub, 1993; Cribb et al., 1995;
Kennison and Russell, 1987), including a dosage-dependent
cascade from one regulator to another (e.g., Schulz and
Tautz, 1994). Also, a screen for dosage-dependent modifiers
of the ectopic expression of Kruppel, which is itself a
dosage-dependent transcription factor, identified a second
tier of regulatory genes that alter its expression (Abrell et
al., 2000). Both long-range and short-range gradients are
involved in making morphological decisions and a change
in concentration of these molecules will alter the pheno-
type (for review, see Christian, 2000). Indeed, some of the
dosage-dependent regulators of white are also involved in
developmental decisions (See Table 1). Moreover, the in-
volvement of gradients in development is a reflection of the
principle that many regulatory mechanisms will evolve to
e males and females. Both transgene insertions are present in a
is of the four genotypes with the X insertion indicates that dosage
n the third chromosome, a slight sexual dimorphism in expression
n the mle/mle mutant males, the expression of the transgene is
tograms represent the mean ratios (6 standard error) of triplicate
ch transgene insertion. The combined results from binding and
on X expression, but, on the autosomes, the increased MOF andle/ml
alys
ne o
er. I
. His
or ea
pactadra et al. (1999) by permission.
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284 Birchler et al.be “rate limiting” on the phenotype in the diploid state and
hence exhibit dosage-dependent behavior when assayed
genetically.
The classical concept of “balance” has also been invoked
as the basis of the developmental process of sex determina-
tion in Drosophila (Bridges, 1925). The immediate trigger is
the splicing state of the Sex-lethal (Sxl) mRNA, which itself
encodes an RNA splicing factor. In females, auto-splicing is
established and self-perpetuating so that a functional pro-
tein is made (Bell et al., 1988, 1991). Males do not express
SXL. The presence or absence of SXL protein in turn affects
a splicing cascade that ultimately determines the activity
state of the transcription factor, doublesex, different forms
of which control the majority of the differences between
males and females (Burtis and Baker, 1989; Cline and
Meyer, 1996). Although the action of Sxl is dichotomous,
its expression is controlled by dosage-dependent transcrip-
tion factors that differ in concentration between males and
females early in development (Erickson and Cline, 1991,
1993). Nevertheless, sex determination can be influenced in
a highly multigenic fashion. Dobzhansky and Schultz
(1931) demonstrated this fact by examining X chromosome
aneuploids of triploid intersexes, which rest on the thresh-
old of the sex-determination switch. Triploid intersexes
have two X chromosomes and three sets of autosomes and
are composed of a mixture of male and female cells. By
introducing deficiencies and duplications along the X in
intersexes, many chromosomal segments were found that
shifted the sexual differentiation. It is possible that, in the
cells of intersexual flies, the dosage-dependent regulators of
Sxl can be modulated easily from the threshold in either
direction. In any one lineage during development, Sxl
splicing will determine either the male or female state, but
the number of lineages of either sex is likely to be influ-
enced by the particular component of the dosage hierarchy
that has been modulated in each individual aneuploid.
SUMMARY
It is becoming clear that the expression of most genes,
metabolic pathways, or developmental processes is affected
by multiple dosage-dependent transcriptional regulators.
Loss-of-function mutations in regulatory genes will most
often exhibit dosage-dependent, semidominant behavior,
whereas those in target housekeeping genes will usually be
recessive when assayed phenotypically. Because regulatory
genes are themselves subject to dosage-dependent regula-
tion, the expression of any structural gene is affected by
numerous regulators acting through intermediates. As a
result, for many different types of target structural genes,
the controlling genes might overlap. The action of the
regulatory genes has implications for developmental
mechanisms, quantitative traits, aneuploid syndromes, and
dosage compensation. Each of these processes has the
potential to be modulated quite subtly by many modifiers.
The meiotic assortment of regulatory gene variation will
Copyright © 2001 by Academic Press. All rightenerate thousands if not millions of possible genotypes,
esulting in a quantitatively distributed array of phenotypes
pon which natural selection can act.
FUTURE ISSUES
Any mutation in a gene involved in regulatory or devel-
opmental processes that gives it an advantage for transmis-
sion to descendents over alternative alleles will be perpetu-
ated. By impacting the phenotype via control over
metabolic or developmental pathways, regulatory processes
evolved to become “rate limiting” at the diploid level. An
important future direction would be to investigate the
interaction of the various modifiers on a single gene or
phenotype. An interesting theoretical offshoot would be to
examine the extent to which different branches of a dosage
hierarchy compete against each other to affect the pheno-
type. The available data suggest that an equilibrium among
at least several branches occurs such that each of these
branches is capable of influencing the phenotype.
Despite the evidence that many regulatory processes are
dosage-dependent, there are several means by which the
mechanism can drift away from being rate limiting in the
diploid state. First, new mutations might occur that alter
the degree of effect of any regulatory pathway on the
phenotype. Another consideration is the impact of pleiot-
ropy. Many of the dosage-dependent factors are quite broad
in their range of target loci, which could affect many
different aspects of the total phenotype. If these different
aspects are under different selective pressures, the conse-
quences for the regulatory process could be conflicted. Also,
neutral aspects of the phenotype will be shifted together
with the aspects under selection. The use of genomic tools
to study global patterns of gene expression will be impor-
tant for addressing these issues from an evolutionary stand-
point. It is important in such studies to determine the gene
expression per cell or per DNA unit rather than relative to
the expression of other genes, as is often applied in differ-
ential display or microarray analyses. This type of compari-
son is necessary because, in many aneuploids, a substantial
fraction of all tested genes is modulated in the same
direction, so relative measurements will mute the magni-
tude of the effect.
Although there is some evidence at the level of target
gene expression for similar dosage effects in mammals
(Klose and Putz, 1983; Reichert, 1986), few studies have
been performed in vertebrates. However, given the similari-
ties among the types of regulatory factors between Dro-
ophila and vertebrates (e.g., Bel et al., 1998), it is unlikely
hat significant differences exist with respect to these types
f dosage effects, but similar studies would confirm or deny
he relationship. Future studies concerning these issues in
ammalian species will impact many subject areas, includ-
ng the evolution of X inactivation, aneuploid syndromes/
irth defects, and the basis of complex genetic traits.
Developmental processes in plants and animals are be-
s of reproduction in any form reserved.
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285Gene Regulation in Multicellular EukaryotesFIG. 5. Reductions in gene expression in aneuploids match the vigor relationship of a dosage series. Monosomic individuals have
eductions due to structural gene dosage effects as well as from positively acting trans-acting effects. The lower limit is 50% of the normal
diploid. Trisomics have reductions in gene expression due to the trans-acting inverse dosage effect. The most severe reductions are 67%
f the normal diploid. If different sets of genes are reduced in expression in the monosomic and trisomic and are rate-limiting on growth
nder the respective situations, the typical vigor relationship of a dosage series would be realized. That is, monosomics are often less
igorous than euploid normals and trisomics are intermediate between the two. This relationship is depicted above with maize plants from
1, 2, 3 dose series for the long arm of chromosome 7. The exact relationship within a dosage series differs from chromosome to
hromosome, which is likely to be due to the different set of genes modulated in each case and the degree to which they impact the
henotype. (Photo by C. B. Carson)
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286 Birchler et al.lieved to have evolved independently, because the common
ancestor for the two taxa was single-celled (Meyerowitz,
1999). Nevertheless, the types of dosage effects observed in
the two kingdoms appear to be quite similar. There is a
multitude of effects; there are both positive and negative
modulations with the latter predominating; the range of
modulation of target genes usually falls within a direct or
inverse correlation with the dosage of the varied regulator.
One explanation for this commonality is that the evolu-
tionary precursor organism had regulatory mechanisms
that behaved in this manner and continued to do so with an
expansion of the number of regulators in the genome.
Recent studies of chromatin remodeling factors in yeast
indicate both negative and positive global modulations of
gene expression (Sudarsanam et al., 2000; Holstege et al.,
1998). However, aneuploid studies in yeast have suggested
that the consequences in this species are not very detrimen-
tal and that the genes on the varied chromosome are not
compensated (Hughes et al., 2000). This interpretation
ssumes that substantial inverse effects were not operative.
f they did indeed occur, gene expression would be reduced
hroughout the genome and unchanged from the varied
hromosome, which would result in the same relative
xpression of the duplicated chromosome to the remainder
f the genome. Nevertheless, the global positive and nega-
ive modulations suggest such action is evolutionarily
rimitive and provide a baseline from which the dosage
ffects might have evolved to their pervasive presence in
ulticellular eukaryotes.
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